{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:52:37Z","timestamp":1769064757916,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jonker-Driessen Foundation"},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["480-08-009"],"award-info":[{"award-number":["480-08-009"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["480-08-009"],"award-info":[{"award-number":["480-08-009"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["480-08-009"],"award-info":[{"award-number":["480-08-009"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-06006-1","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T03:13:42Z","timestamp":1726456422000},"page":"5511-5525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry"],"prefix":"10.1007","volume":"103","author":[{"given":"Afke","family":"Ekels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lonneke V.","family":"van de Poll-Franse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djamila E.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mels","family":"Hoogendoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marten R.","family":"Nijziel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianus","family":"Koster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis N.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Achouiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noortje","family":"Thielen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidwine W.","family":"Tick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liane C. J.","family":"te Boome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara H.","family":"Bohmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolette L.","family":"Tiren-Verbeet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit J.","family":"Veldhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fransien","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein","family":"van der Klift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardus F. M.","family":"Posthuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Oerlemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"11","key":"6006_CR1","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1016\/S2352-3026(21)00241-6","volume":"8","author":"R Cordoba","year":"2021","unstructured":"Cordoba R et al (2021) A comprehensive approach to therapy of haematological malignancies in older patients. Lancet Haematol 8(11):e840\u2013e852","journal-title":"Lancet Haematol"},{"key":"6006_CR2","unstructured":"The Netherlands Comprehensive Cancer Organisation (IKNL). Netherlands Cancer Registry application (2022) ; www.iknl.nl\/nkr-cijfers"},{"issue":"1","key":"6006_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/10428190701724785","volume":"49","author":"P Thurmes","year":"2008","unstructured":"Thurmes P et al (2008) Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymphoma 49(1):49\u201356","journal-title":"Leuk Lymphoma"},{"key":"6006_CR4","doi-asserted-by":"publisher","unstructured":"Ekels A et al (2023) The course of self-perceived cognitive functioning among patients with lymphoma and the co-occurrence with fatigue and psychological distress. J Cancer Surviv. https:\/\/doi.org\/10.1007\/s11764-023-01458-2","DOI":"10.1007\/s11764-023-01458-2"},{"issue":"7","key":"6006_CR5","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1097\/HS9.0000000000000744","volume":"6","author":"MC Bennink","year":"2022","unstructured":"Bennink MC et al (2022) Impact of comorbidities on Health-related quality of life in Nontransplant Eligible patients with newly diagnosed multiple myeloma. Hemasphere 6(7):e744","journal-title":"Hemasphere"},{"key":"6006_CR6","doi-asserted-by":"publisher","first-page":"32566","DOI":"10.1038\/srep32566","volume":"6","author":"J Yang","year":"2016","unstructured":"Yang J et al (2016) Discover the network underlying the connections between aging and age-related diseases. Sci Rep 6:32566","journal-title":"Sci Rep"},{"issue":"10","key":"6006_CR7","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/pon.4845","volume":"27","author":"A Cummings","year":"2018","unstructured":"Cummings A et al (2018) Comorbidities are associated with poorer quality of life and functioning and worse symptoms in the 5 years following colorectal cancer surgery: results from the ColoREctal Well-being (CREW) cohort study. Psychooncology 27(10):2427\u20132435","journal-title":"Psychooncology"},{"issue":"5","key":"6006_CR8","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s11764-018-0708-6","volume":"12","author":"H G\u00f6tze","year":"2018","unstructured":"G\u00f6tze H et al (2018) Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. J Cancer Surviv 12(5):712\u2013720","journal-title":"J Cancer Surviv"},{"issue":"7","key":"6006_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41375-018-0325-4","volume":"33","author":"F Efficace","year":"2019","unstructured":"Efficace F et al (2019) Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia. Leukemia 33(7):1598\u20131607","journal-title":"Leukemia"},{"issue":"4","key":"6006_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s11764-013-0299-1","volume":"7","author":"PA Vissers","year":"2013","unstructured":"Vissers PA et al (2013) The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Surviv 7(4):602\u2013613","journal-title":"J Cancer Surviv"},{"issue":"5","key":"6006_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"issue":"6","key":"6006_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649\u2013655","journal-title":"Am J Clin Oncol"},{"issue":"13","key":"6006_CR13","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","volume":"125","author":"A Palumbo","year":"2015","unstructured":"Palumbo A et al (2015) Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood 125(13):2068\u20132074","journal-title":"Blood"},{"issue":"2","key":"6006_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3324\/haematol.2017.174573","volume":"103","author":"F Gay","year":"2018","unstructured":"Gay F et al (2018) From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives. Haematologica 103(2):197\u2013211","journal-title":"Haematologica"},{"issue":"3","key":"6006_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/jamaoncol.2018.5953","volume":"5","author":"JM Unger","year":"2019","unstructured":"Unger JM et al (2019) Association of Patient Comorbid conditions with Cancer Clinical Trial Participation. JAMA Oncol 5(3):326\u2013333","journal-title":"JAMA Oncol"},{"issue":"7","key":"6006_CR16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ctrv.2013.01.007","volume":"39","author":"C Bellera","year":"2013","unstructured":"Bellera C et al (2013) Barriers to inclusion of older adults in randomised controlled clinical trials on Non-hodgkin\u2019s lymphoma: a systematic review. Cancer Treat Rev 39(7):812\u2013817","journal-title":"Cancer Treat Rev"},{"key":"6006_CR17","doi-asserted-by":"publisher","first-page":"1214026","DOI":"10.3389\/fonc.2023.1214026","volume":"13","author":"A Arcari","year":"2023","unstructured":"Arcari A et al (2023) New treatment options in elderly patients with diffuse large B-cell lymphoma. Front Oncol 13:1214026","journal-title":"Front Oncol"},{"issue":"2","key":"6006_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41408-021-00432-4","volume":"11","author":"E Terpos","year":"2021","unstructured":"Terpos E et al (2021) Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood Cancer J 11(2):40","journal-title":"Blood Cancer J"},{"key":"6006_CR19","doi-asserted-by":"crossref","unstructured":"Davies A et al (2020) Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma. Ann Hematol","DOI":"10.1007\/s00277-020-04021-6"},{"issue":"2","key":"6006_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00277-016-2878-5","volume":"96","author":"BD Cheson","year":"2017","unstructured":"Cheson BD et al (2017) Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone. Ann Hematol 96(2):253\u2013259","journal-title":"Ann Hematol"},{"issue":"4","key":"6006_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.clml.2016.01.001","volume":"16","author":"JM Burke","year":"2016","unstructured":"Burke JM et al (2016) Differences in quality of life between bendamustine-rituximab and R-CHOP\/R-CVP in patients with previously untreated Advanced Indolent Non-hodgkin Lymphoma or Mantle Cell Lymphoma. Clin Lymphoma Myeloma Leuk 16(4):182\u2013190e1","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"6006_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00277-021-04705-7","volume":"101","author":"AC Paunescu","year":"2022","unstructured":"Paunescu AC et al (2022) Correction to: quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study. Ann Hematol 101(2):333","journal-title":"Ann Hematol"},{"issue":"5","key":"6006_CR23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/bjh.18139","volume":"197","author":"A Ekels","year":"2022","unstructured":"Ekels A et al (2022) Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-hodgkin lymphoma survivors: a longitudinal PROFILES registry study. Br J Haematol 197(5):590\u2013601","journal-title":"Br J Haematol"},{"issue":"9","key":"6006_CR24","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00277-011-1274-4","volume":"90","author":"S Oerlemans","year":"2011","unstructured":"Oerlemans S et al (2011) The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin\u2019s and Non-hodgkin\u2019s lymphoma survivors: a systematic review. Ann Hematol 90(9):993\u20131004","journal-title":"Ann Hematol"},{"issue":"24","key":"6006_CR25","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1200\/JCO.2013.55.0418","volume":"32","author":"A Hurria","year":"2014","unstructured":"Hurria A et al (2014) Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol 32(24):2587\u20132594","journal-title":"J Clin Oncol"},{"issue":"1","key":"6006_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1740774520975120","volume":"18","author":"E Basch","year":"2021","unstructured":"Basch E et al (2021) Composite grading algorithm for the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Clin Trials 18(1):104\u2013114","journal-title":"Clin Trials"},{"key":"6006_CR27","doi-asserted-by":"crossref","unstructured":"van de Poll-Franse LV et al (2011) The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. 47(14): pp. 2188\u20132194","DOI":"10.1016\/j.ejca.2011.04.034"},{"key":"6006_CR28","unstructured":"Jack A et al (2000) International classification of diseases for oncology: ICD-O. World Health Organization"},{"issue":"2","key":"6006_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/art.10993","volume":"49","author":"O Sangha","year":"2003","unstructured":"Sangha O et al (2003) The self-administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Care Research: Official J Am Coll Rheumatol 49(2):156\u2013163","journal-title":"Arthritis Care Research: Official J Am Coll Rheumatol"},{"issue":"5","key":"6006_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI: J Natl Cancer Inst 85(5):365\u2013376","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"22","key":"6006_CR31","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1182\/bloodadvances.2023010841","volume":"7","author":"S Oerlemans","year":"2023","unstructured":"Oerlemans S et al (2023) International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27. Blood Adv 7(22):7045\u20137055","journal-title":"Blood Adv"},{"issue":"17","key":"6006_CR32","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/cncr.34822","volume":"129","author":"S Oerlemans","year":"2023","unstructured":"Oerlemans S et al (2023) International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-hodgkin lymphoma (QLQ-NHL-LG20). Cancer 129(17):2727\u20132740","journal-title":"Cancer"},{"issue":"1","key":"6006_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks K et al (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 29(1):89\u201396","journal-title":"J Clin Oncol"},{"issue":"11","key":"6006_CR34","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","volume":"48","author":"K Cocks","year":"2012","unstructured":"Cocks K et al (2012) Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer 48(11):1713\u20131721","journal-title":"Eur J Cancer"},{"issue":"35","key":"6006_CR35","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1200\/JCO.22.02776","volume":"41","author":"D Osoba","year":"2023","unstructured":"Osoba D et al (2023) Interpreting the significance of changes in Health-Related Quality-of-life scores. J Clin Oncol 41(35):5345\u20135350","journal-title":"J Clin Oncol"},{"issue":"1","key":"6006_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139\u2013144","journal-title":"J Clin Oncol"},{"key":"6006_CR37","doi-asserted-by":"publisher","unstructured":"van de Poll-Franse LV et al (2011) Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer. 47(5):667\u2013675. https:\/\/doi.org\/10.1016\/j.ejca.2010.11.004","DOI":"10.1016\/j.ejca.2010.11.004"},{"issue":"6","key":"6006_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E et al (2016) Symptom Monitoring with patient-reported outcomes during Routine Cancer treatment: a Randomized Controlled Trial. J Clin Oncol 34(6):557\u2013565","journal-title":"J Clin Oncol"},{"issue":"6","key":"6006_CR39","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.3390\/curroncol29060349","volume":"29","author":"CJG van den Hurk","year":"2022","unstructured":"van den Hurk CJG et al (2022) A narrative review on the Collection and Use of Electronic patient-reported outcomes in Cancer Survivorship Care with emphasis on Symptom Monitoring. Curr Oncol 29(6):4370\u20134385","journal-title":"Curr Oncol"},{"issue":"2","key":"6006_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bbmt.2019.10.002","volume":"26","author":"GE Georges","year":"2020","unstructured":"Georges GE et al (2020) Survivorship after autologous hematopoietic cell transplantation for Lymphoma and multiple myeloma: late effects and Quality of Life. Biol Blood Marrow Transpl 26(2):407\u2013412","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"6006_CR41","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ajh.26596","volume":"98","author":"A D\u2019Souza","year":"2023","unstructured":"D\u2019Souza A et al (2023) Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma. Am J Hematol 98(1):140\u2013147","journal-title":"Am J Hematol"},{"issue":"9","key":"6006_CR42","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s11136-006-0025-9","volume":"15","author":"CE Schwartz","year":"2006","unstructured":"Schwartz CE et al (2006) The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res 15(9):1533\u20131550","journal-title":"Qual Life Res"},{"issue":"4","key":"6006_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-0609.2012.01831.x","volume":"89","author":"F Mols","year":"2012","unstructured":"Mols F et al (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 year after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89(4):311\u2013319","journal-title":"Eur J Haematol"},{"issue":"3","key":"6006_CR44","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00277-022-05070-9","volume":"102","author":"NC van Yperen","year":"2023","unstructured":"van Yperen NC et al (2023) Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after stem cell trAnsplantation (MOSA). Ann Hematol 102(3):641\u2013649","journal-title":"Ann Hematol"},{"issue":"6","key":"6006_CR45","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s11764-019-00793-7","volume":"13","author":"I Ramsey","year":"2019","unstructured":"Ramsey I et al (2019) Cancer survivors who fully participate in the PROFILES registry have better health-related quality of life than those who drop out. J Cancer Surviv 13(6):829\u2013839","journal-title":"J Cancer Surviv"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06006-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:09:19Z","timestamp":1735866559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06006-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6006"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06006-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from a certified Medical Ethics Committee (of the Maxima Medical Centre in Veldhoven, the Netherlands; NL20.011 and NL78561.015.21).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for collecting data was obtained from all patients participating in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}